Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

Bibliographic Details
Main Authors:	Giulia Pinton, Zhuo Wang, Cecilia Balzano, Sara Missaglia, Daniela Tavian, Renzo Boldorini, Dean A. Fennell, Martin Griffin, Laura Moro
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	malignant pleural mesothelioma EZH2 inhibitor CDKN2A/p16ink4a TG2 multicellular spheroids
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1081632/full

Similar Items

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
by: Giulia Pinton, et al.
Published: (2021-07-01)

Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids
by: Silvia Mola, et al.
Published: (2021-04-01)

Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
by: MHD Ouis Al Khatib, et al.
Published: (2023-02-01)

Ezh2 Regulates Activation-Induced CD8+ T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
by: Guobing Chen, et al.
Published: (2018-03-01)

Pleural mesothelioma metastasis of the scalp
by: Tugcem Bicak, et al.
Published: (2024-02-01)

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
by: Eeva Kettunen, et al.
Published: (2019-05-01)

Precision Therapy for Mesothelioma: Feasibility and New Opportunities
by: Sean Dulloo, et al.
Published: (2021-05-01)

CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation
by: Yuen Yee Cheng, et al.
Published: (2020-11-01)

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment
by: Sara Boumya, et al.
Published: (2023-04-01)

Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma
by: Miho Yoshida, et al.
Published: (2023-11-01)

<i>TP53</i>-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
by: Lennart Versemann, et al.
Published: (2022-07-01)

Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
by: Federica Borea, et al.
Published: (2023-05-01)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
by: E. Genescà, et al.
Published: (2018-07-01)

Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
by: Ran Zhao, et al.
Published: (2016-06-01)

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
by: Sophie Sneddon, et al.
Published: (2017-06-01)

Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma
by: Hui Xing, et al.
Published: (2022-05-01)

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2
by: Mengjun Guo, et al.
Published: (2022-03-01)

Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study
by: Federica Pezzuto, et al.
Published: (2020-06-01)

Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b
by: Christos Demosthenous, et al.
Published: (2020-07-01)

Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells
by: Ming Bai, et al.
Published: (2016-12-01)

Antagonistic interaction between Ezh2 and Arid1a coordinates root patterning and development via Cdkn2a in mouse molars
by: Junjun Jing, et al.
Published: (2019-07-01)

Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
by: Yahui Kong, et al.
Published: (2018-07-01)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
by: Marion Grard, et al.
Published: (2021-06-01)

EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
by: Bohan Wang, et al.
Published: (2023-06-01)

Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells
by: Daolu Yang, et al.
Published: (2021-03-01)

Association of CDKN2A/B gene polymorphisms (rs10811661 and rs2383208) with type 2 diabetes mellitus in a sample of Iraqi population
by: Hussein K. Fadheel, et al.
Published: (2022-03-01)

Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas
by: Daniel F. Marker, et al.
Published: (2020-10-01)

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
by: Moshe Lapidot, et al.
Published: (2022-01-01)

Diffuse Peritoneal Malignant Mesothelioma Presenting with Abnormal Uterine Bleeding: Case Report
by: Ivana Rizzuto, et al.
Published: (2022-03-01)

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report
by: Vallari Shah, et al.
Published: (2017-11-01)

Malignant mesothelioma
by: Suzanne Alkul, et al.
Published: (2016-04-01)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
by: Federica Pezzuto, et al.
Published: (2021-07-01)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01)

<i>CDKN2A</i> Gene Mutations: Implications for Hereditary Cancer Syndromes
by: Anastasiia Danishevich, et al.
Published: (2023-12-01)

Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)

SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters
by: Elisabeth Groß, et al.
Published: (2023-06-01)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
by: Valeria Musso, et al.
Published: (2021-09-01)

Primary adrenocortical carcinoma with mutation in the CDKN2A gene
by: Changming Dong, et al.
Published: (2023-09-01)

Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma
by: Andreas Gutzeit, et al.
Published: (2013-04-01)